Tocilizumab (RoActemra) and Tranexamic Acid (Cyklokapron) Used as Adjuncts to Chronic Subdural Hematoma Surgery
Clinical trial NCT03353259 · TERMINATED
Trial details
- NCT number
- NCT03353259
- Sponsor
- Oslo University Hospital
- Status
- TERMINATED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-28
- Primary completion
- 2021-02-28
- Enrollment
- 382
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.